{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:43:26Z","timestamp":1780461806296,"version":"3.54.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>The Fontan procedure has transformed the management of congenital heart defects characterized by single ventricle physiology, yet it predisposes individuals to Fontan-associated liver disease. Combined heart and liver transplantation (CHLT) emerges as a therapeutic option, but evidence of its efficacy and safety remains limited. This study aimed to comprehensively evaluate CHLT in Fontan patients, focusing on patient characteristics, perioperative outcomes, and posttransplant morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a systematic search of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was conducted. Studies meeting the intervention of CHLT in Fontan patients were included, and data were collected and synthesized using proportion meta-analysis techniques. Statistical analysis was carried out using R software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Four studies met inclusion criteria, comprising 67 Fontan patients undergoing CHLT. All included studies were observational retrospective cohorts performed in the United States. The 1-y survival rate post-CHLT was 88% (95% confidence interval [CI], 70%-98%). Liver graft rejection rates were low, 4% (95% CI, 0%-22%), and no heart graft rejection greater than mild was reported. Postoperative complications included acute kidney injury 75% (95% CI, 50%-93%), temporary dialysis 27% (95% CI, 9%-51%), neurologic events 7% (95% CI, 0%-26%), infection 23% (95% CI, 3%-55%), and unplanned medical procedures 40% (95% CI, 23%-59%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>CHLT in Fontan patients demonstrates promising survival rates, but graft rejection and postoperative complications pose challenges. The rate of renal complications is particularly notable and requires further evaluation. Future research should prioritize comparative different management strategies and long-term follow-up to refine protocols and optimize outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000005400","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:36Z","timestamp":1746403236000},"page":"1783-1791","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Combined Heart and Liver Transplantation in the Failing Fontan: Systematic Review and Single-arm Meta-analysis"],"prefix":"10.1097","volume":"109","author":[{"given":"Vanessa","family":"Karlinski Vizentin","sequence":"first","affiliation":[{"name":"Cardiovascular Diseases Department, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanio","family":"Antunes","sequence":"additional","affiliation":[{"name":"Medicine Department, Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuri","family":"Ferreira Felix","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Florencio de Mesquita","sequence":"additional","affiliation":[{"name":"Federal University of Pernambuco, Recife, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u00edsio","family":"Bulh\u00f5es","sequence":"additional","affiliation":[{"name":"Medicine Department, Faculty of Higher Superior of the Amazon Reunida, Reden\u00e7\u00e3o, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Ameduri","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology Department, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology Department, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"R1-20251023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21037\/tp-22-573","article-title":"Narrative review of single ventricle: where are we after 40 years?","volume":"12","author":"Corno","year":"2023","journal-title":"Transl Pediatr"},{"key":"R2-20251023","doi-asserted-by":"crossref","first-page":"290","DOI":"10.21037\/tp.2019.06.03","article-title":"Transplantation of the failing Fontan.","volume":"8","author":"McCormick","year":"2019","journal-title":"Transl Pediatr"},{"key":"R3-20251023","doi-asserted-by":"crossref","first-page":"1020984","DOI":"10.3389\/fped.2022.1020984","article-title":"Management of circulatory failure after Fontan surgery.","volume":"10","author":"Kamsheh","year":"2022","journal-title":"Front Pediatr"},{"key":"R4-20251023","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease: screening, management, and transplant considerations.","volume":"142","author":"Emamaullee","year":"2020","journal-title":"Circulation"},{"key":"R5-20251023","first-page":"e698","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Stout","year":"2019","journal-title":"Circulation"},{"key":"R6-20251023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"R7-20251023","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/CIR.0000000000000204","article-title":"Congenital heart disease in the older adult: a scientific statement from the American Heart Association.","volume":"131","author":"Bhatt","year":"2015","journal-title":"Circulation"},{"key":"R8-20251023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/heartjnl-2019-314937","article-title":"Management of the adult Fontan patient.","volume":"106","author":"Rodriguez","year":"2020","journal-title":"Heart"},{"key":"R9-20251023","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.amjcard.2013.08.023","article-title":"Hemodynamic phenotype of the failing Fontan in an adult population.","volume":"112","author":"Hebson","year":"2013","journal-title":"Am J Cardiol"},{"key":"R10-20251023","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"Bmj"},{"key":"R11-20251023","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions.","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Meth"},{"key":"R12-20251023","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range.","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"R13-20251023","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range.","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"R14-20251023","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jacc.2023.03.421","article-title":"Clinical outcomes of adult fontan-associated liver disease and combined heart-liver transplantation.","volume":"81","author":"Lewis","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R15-20251023","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.jvca.2023.11.043","article-title":"Perioperative characteristics and outcomes of fontan versus non-Fontan patients undergoing combined heart-liver transplantation: a retrospective cohort study.","volume":"38","author":"Wu","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R16-20251023","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.healun.2020.12.008","article-title":"Comparison of combined heart\u2013liver vs heart-only transplantation in pediatric and young adult Fontan recipients.","volume":"40","author":"Sganga","year":"2021","journal-title":"J heart lung transplant"},{"key":"R17-20251023","article-title":"Single-center outcomes of combined heart and liver transplantation in the failing Fontan.","volume":"31","author":"D\u2019Souza","year":"2017","journal-title":"Clin Transplant"},{"key":"R18-20251023","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.","volume":"24","author":"Stewart","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R19-20251023","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jamcollsurg.2011.12.039","article-title":"Liver transplantation with preservation of the inferior vena cava: lessons learned through 2,000 cases.","volume":"214","author":"Levi","year":"2012","journal-title":"J Am Coll Surg"},{"key":"R20-20251023","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jtcvs.2021.11.054","article-title":"Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: an analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs Databases.","volume":"164","author":"Bedzra","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R21-20251023","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.pcsu.2020.02.007","article-title":"Ventricular assist device therapy and Fontan: a story of supply and demand.","volume":"23","author":"Villa","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"R22-20251023","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.028","article-title":"The International Society for Heart and Lung Transplantation\/Heart Failure Society of America guideline on acute mechanical circulatory support.","volume":"42","author":"Bernhardt","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R23-20251023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.gastro.2010.10.059","article-title":"Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs.","volume":"140","author":"S\u00e1nchez-Fueyo","year":"2011","journal-title":"Gastroenterology"},{"key":"R24-20251023","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1111\/ajt.13870","article-title":"Liver allograft provides immunoprotection for the cardiac allograft in combined heart-liver transplantation.","volume":"16","author":"Wong","year":"2016","journal-title":"Am J Transplant"},{"key":"R25-20251023","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jacc.2021.01.013","article-title":"Heart-after-liver transplantation attenuates rejection of cardiac allografts in sensitized patients.","volume":"77","author":"Daly","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R26-20251023","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2023.03.422","article-title":"Morbidity and mortality in adult fontan patients after heart or combined heart-liver transplantation.","volume":"81","author":"Lewis","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R27-20251023","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/phar.2716","article-title":"Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation.","volume":"42","author":"Nelson","year":"2022","journal-title":"Pharmacotherapy"},{"key":"R28-20251023","doi-asserted-by":"crossref","first-page":"e13329","DOI":"10.1111\/ctr.13329","article-title":"Heart and heart-liver transplantation in adults with failing Fontan physiology.","volume":"32","author":"Reardon","year":"2018","journal-title":"Clin Transplant"},{"key":"R29-20251023","first-page":"1002","article-title":"Hepatic and renal consequences of single-ventricle physiology palliated with the fontan operation.","volume":"38","author":"Rathgeber","year":"2022","journal-title":"Can J Cardiol"},{"key":"R30-20251023","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.amjcard.2021.08.056","article-title":"Acute kidney injury and renal replacement therapy after Fontan operation.","volume":"161","author":"Niaz","year":"2021","journal-title":"Am J Cardiol"},{"key":"R31-20251023","doi-asserted-by":"crossref","first-page":"e13401","DOI":"10.1111\/ctr.13401","article-title":"Predictors of renal replacement therapy after heart transplantation and its impact on long-term survival.","volume":"32","author":"Ivey-Miranda","year":"2018","journal-title":"Clin Transplant"},{"key":"R32-20251023","doi-asserted-by":"crossref","first-page":"e1585","DOI":"10.1097\/TXD.0000000000001585","article-title":"Severe acute kidney injury postheart transplantation: analysis of risk factors.","volume":"10","author":"Gale","year":"2024","journal-title":"Transplant Direct"},{"key":"R33-20251023","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00246-023-03334-3","article-title":"Long-Term renal involvement in association with Fontan circulation.","volume":"45","author":"Muraoka","year":"2024","journal-title":"Pediatr Cardiol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005400","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:04:13Z","timestamp":1761224653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005400","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}